Booz Allen Hamilton to Acquire Peraton Labs for $300M
Ticker: BAH · Form: 8-K · Filed: Jun 4, 2025 · CIK: 1443646
Sentiment: bullish
Topics: acquisition, technology, government-contracts, ai
Related Tickers: PRT
TL;DR
BAH buying Peraton Labs for $300M to boost AI/cyber tech. Big government play.
AI Summary
Booz Allen Hamilton Holding Corp. announced on June 4, 2025, that it has entered into a definitive agreement to acquire Peraton Labs, a subsidiary of Peraton Inc., for $300 million. The acquisition is expected to close in the second quarter of fiscal year 2026 and will enhance Booz Allen's capabilities in areas such as artificial intelligence, cyber, and advanced engineering.
Why It Matters
This acquisition significantly expands Booz Allen's technological capabilities, particularly in AI and cyber, positioning them for increased government contract wins.
Risk Assessment
Risk Level: medium — The acquisition carries integration risks and depends on regulatory approvals and achieving projected synergies.
Key Numbers
- $300M — Acquisition Price (Cost to acquire Peraton Labs)
Key Players & Entities
- Booz Allen Hamilton Holding Corp. (company) — Acquiring company
- Peraton Labs (company) — Acquired company
- Peraton Inc. (company) — Parent company of acquired entity
- $300 million (dollar_amount) — Purchase price
- June 4, 2025 (date) — Announcement date
- second quarter of fiscal year 2026 (date) — Expected closing period
FAQ
What specific capabilities will Peraton Labs bring to Booz Allen Hamilton?
Peraton Labs will enhance Booz Allen's capabilities in artificial intelligence, cyber, and advanced engineering, particularly in areas like secure cloud, AI/ML, and quantum sciences.
When is the acquisition expected to be completed?
The acquisition is anticipated to close in the second quarter of fiscal year 2026.
What is the financial impact of this acquisition on Booz Allen Hamilton?
Booz Allen Hamilton is acquiring Peraton Labs for $300 million, which is expected to be funded through cash on hand and potentially debt.
Who is the seller of Peraton Labs?
Peraton Labs is a subsidiary of Peraton Inc.
What is the strategic rationale behind this acquisition?
The acquisition aims to accelerate Booz Allen's strategy by expanding its technology differentiation and enhancing its ability to deliver advanced solutions to government clients.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 4, 2025 regarding Booz Allen Hamilton Holding Corp (BAH).